Category
Cancer
Sub Category
Glioblastoma
Study Name
RTOG 1122 Phase II Double blinded Placebo Controlled Study of Bevacizumab with or without AMG 386 in patients with Recurrent Glioblastoma or Gliosarcoma
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance